BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 26330511)

  • 1. Stationary-Phase Persisters to Ofloxacin Sustain DNA Damage and Require Repair Systems Only during Recovery.
    Völzing KG; Brynildsen MP
    mBio; 2015 Sep; 6(5):e00731-15. PubMed ID: 26330511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of DNA damage responses impacts persistence to fluoroquinolones.
    Mok WWK; Brynildsen MP
    Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6301-E6309. PubMed ID: 29915065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (p)ppGpp-Dependent Persisters Increase the Fitness of Escherichia coli Bacteria Deficient in Isoaspartyl Protein Repair.
    VandenBerg KE; Ahn S; Visick JE
    Appl Environ Microbiol; 2016 Sep; 82(17):5444-54. PubMed ID: 27371580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxin Induction or Inhibition of Transcription or Translation Posttreatment Increases Persistence to Fluoroquinolones.
    Lemma AS; Brynildsen MP
    mBio; 2021 Aug; 12(4):e0198321. PubMed ID: 34399616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell imaging and characterization of
    Goormaghtigh F; Van Melderen L
    Sci Adv; 2019 Jun; 5(6):eaav9462. PubMed ID: 31223653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced antibiotic resistance development from fluoroquinolone persisters after a single exposure to antibiotic.
    Barrett TC; Mok WWK; Murawski AM; Brynildsen MP
    Nat Commun; 2019 Mar; 10(1):1177. PubMed ID: 30862812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the Effects of Osmolytes and Environmental pH on Bacterial Persisters.
    Karki P; Mohiuddin SG; Kavousi P; Orman MA
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disrupting folate metabolism reduces the capacity of bacteria in exponential growth to develop persisters to antibiotics.
    Morgan J; Smith M; Mc Auley MT; Enrique Salcedo-Sora J
    Microbiology (Reading); 2018 Nov; 164(11):1432-1445. PubMed ID: 30247120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential impacts of DNA repair machinery on fluoroquinolone persisters with different chromosome abundances.
    Tang J; Herzfeld AM; Leon G; Brynildsen MP
    mBio; 2024 May; 15(5):e0037424. PubMed ID: 38564687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dormancy is not necessary or sufficient for bacterial persistence.
    Orman MA; Brynildsen MP
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3230-9. PubMed ID: 23629720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotic Escherichia coli Nissle 1917 inhibits bacterial persisters that survive fluoroquinolone treatment.
    Hare PJ; Englander HE; Mok WWK
    J Appl Microbiol; 2022 Jun; 132(6):4020-4032. PubMed ID: 35332984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells.
    Harms A; Fino C; Sørensen MA; Semsey S; Gerdes K
    mBio; 2017 Dec; 8(6):. PubMed ID: 29233898
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Mohiuddin SG; Massahi A; Orman MA
    mBio; 2022 Feb; 13(1):e0218721. PubMed ID: 35038905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persister Heterogeneity Arising from a Single Metabolic Stress.
    Amato SM; Brynildsen MP
    Curr Biol; 2015 Aug; 25(16):2090-8. PubMed ID: 26255847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reassessing the Role of Type II Toxin-Antitoxin Systems in Formation of Escherichia coli Type II Persister Cells.
    Goormaghtigh F; Fraikin N; Putrinš M; Hallaert T; Hauryliuk V; Garcia-Pino A; Sjödin A; Kasvandik S; Udekwu K; Tenson T; Kaldalu N; Van Melderen L
    mBio; 2018 Jun; 9(3):. PubMed ID: 29895634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Freezing Enables Aminoglycosides To Eradicate Bacterial Persisters via Enhancing Mechanosensitive Channel MscL-Mediated Antibiotic Uptake.
    Zhao Y; Lv B; Sun F; Liu J; Wang Y; Gao Y; Qi F; Chang Z; Fu X
    mBio; 2020 Feb; 11(1):. PubMed ID: 32047133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The AcrAB-TolC Efflux Pump Impacts Persistence and Resistance Development in Stationary-Phase Escherichia coli following Delafloxacin Treatment.
    Byrd BA; Zenick B; Rocha-Granados MC; Englander HE; Hare PJ; LaGree TJ; DeMarco AM; Mok WWK
    Antimicrob Agents Chemother; 2021 Jul; 65(8):e0028121. PubMed ID: 34097492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Dynamic Transition of Persistence toward the Viable but Nonculturable State during Stationary Phase Is Driven by Protein Aggregation.
    Dewachter L; Bollen C; Wilmaerts D; Louwagie E; Herpels P; Matthay P; Khodaparast L; Khodaparast L; Rousseau F; Schymkowitz J; Michiels J
    mBio; 2021 Aug; 12(4):e0070321. PubMed ID: 34340538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ploidy is an important determinant of fluoroquinolone persister survival.
    Murawski AM; Brynildsen MP
    Curr Biol; 2021 May; 31(10):2039-2050.e7. PubMed ID: 33711253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific Enrichment and Proteomics Analysis of Escherichia coli Persisters from Rifampin Pretreatment.
    Sulaiman JE; Hao C; Lam H
    J Proteome Res; 2018 Nov; 17(11):3984-3996. PubMed ID: 30336045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.